oxycodone has been researched along with quinine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bochner, F; Cleary, J; Mikus, G; Somogyi, A | 1 |
| Ahmad, R; Davies, AN; Hirani, E; Hume, SP; Lingford-Hughes, AR; Nataf, V; Nutt, DJ | 1 |
| Babalonis, S; Hampson, AJ; Lofwall, MR; Nuzzo, PA; Walsh, SL | 1 |
1 review(s) available for oxycodone and quinine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for oxycodone and quinine
| Article | Year |
|---|---|
Quinine as a potential tracer for medication adherence: A pharmacokinetic and pharmacodynamic assessment of quinine alone and in combination with oxycodone in humans.
Topics: Adolescent; Adult; Biomarkers; Blood Gas Monitoring, Transcutaneous; Blood Pressure; Double-Blind Method; Drug Interactions; Female; Heart Rate; Humans; Male; Medication Adherence; Middle Aged; Oxycodone; Pupil; Quinine; Respiratory Rate; Young Adult | 2015 |
6 other study(ies) available for oxycodone and quinine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model.
Topics: Analgesia; Animals; Codeine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Female; Mixed Function Oxygenases; Morphine; Oxycodone; Oxymorphone; Quinine; Rats; Rats, Sprague-Dawley | 1994 |
Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opiates.
Topics: Analgesics, Opioid; Animals; Brain; Brain Stem; Buprenorphine; Carbon Radioisotopes; Cerebellum; Competitive Bidding; Diprenorphine; Limbic System; Male; Morphine; Narcotic Antagonists; Oxycodone; Positron-Emission Tomography; Prosencephalon; Quinine; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Reproducibility of Results; Tissue Distribution | 2007 |